Nova Scotia Health Research Foundation
15
3
4
6
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 40/100
6.7%
1 terminated/withdrawn out of 15 trials
85.7%
-0.8% vs industry average
33%
5 trials in Phase 3/4
0%
0 of 6 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (15)
Comprehensive Assessment of Neurodegeneration and Dementia
Role: collaborator
The Canadian Depression Research and Intervention Network (CDRIN) Maritimes Registry
Role: collaborator
Skills for Wellness
Role: collaborator
Sidestream Dark-Field (SDF) Imaging of the Intestinal Microcirculation
Role: collaborator
Making Memory Better for Seniors With Mild Cognitive Impairment
Role: collaborator
Methadone in Neuropathic Pain
Role: collaborator
The Influence of Skin-to-skin Contact on Cortical Activity During Painful Procedures on Preterm Infants in the NICU
Role: collaborator
Testing myWHI: Online Self-help Programs for Headaches
Role: collaborator
Combined Effects of Aerobic Exercise and Cognitive Training on Cognition After Stroke
Role: collaborator
Atrial Substrate Modification With Aggressive Blood Pressure Lowering to Prevent AF
Role: collaborator
Trial of Repeated Analgesia With Kangaroo Care - 18 Month Follow-up
Role: collaborator
Trial of Repeated Analgesia With Kangaroo Care
Role: collaborator
Palliation of Dyspnea in Advanced Chronic Obstructive Pulmonary Disease (COPD)
Role: collaborator
Neuroimaging Predictors of Treatment Failure in Adult New-onset Epilepsy
Role: collaborator
Prevention of Instent Renarrowing With Aggressive Glucose Lowering With Pioglitazone in Diabetic Patients
Role: collaborator
All 15 trials loaded